Prognostic factors in cystosarcoma phyllodes. A clinicopathologic study of 77 patients
✍ Scribed by Gabriella Cohn-Cedermark; Lars E. Rutqvist; Ingvar Rosendahl; Claes Silfverswärd
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 613 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
The authors studied prognostic factors in 77 patients with primary cystosarcoma phyllodes (CSP) of the breast. Median patient age was 50 years of age, and the median follow-up time was 8 years. Sixteen patients (21'/0) had distant metastases and subsequently died of CSP. Clinical variables such as age, symptom duration, clinical tumor size, and type of surgery were not of prognostic value. Local recurrence was more common among patients treated with breast-conserving surgery than among those treated with mastectomy. However, there was no significant difference between these two subgroups in terms of distant metastasisfree survival or overall survival. The prognostic significance of several histopathologic parameters was also assessed, e.g., stromal cellularity, stromal cellular atypism, mitotic activity, atypic mitoses, stromal overgrowth, tumor contour, tumor necrosis, and heterologous stromal elements. In a multivariate Cox analysis, the only features that were found to be independent prognostic factors were tumor necrosis ( P < 0.05) and presence of stromal elements other than fibromyxoid tissue (P < 0.01). In summary, additional studies of prognostic factors in CSP are warranted because of the conflicting results in published reports.
📜 SIMILAR VOLUMES
## Background: Carcinosarcoma (malignant mixed mullerian tumor) of the female genital tract is a highly malignant neoplasm. the tumor stage and histologic grade of the carcinomatous component are among the important prognostic indicators cited in the literature for this tumor. ## Methods: Twenty-
## BACKGROUND. Up to now, the expression of the tumor-associated Thomsen-Friedenreich (TF) antigen in colorectal carcinoma has not been thoroughly investigated with particular emphasis on its correlation with established clinicopathologic characteristics and classifications as well as its prognosti